Deals
Boston Scientific to Buy Endoscopy Company in $210M Deal
This article is for subscribers only.
Boston Scientific Corp. agreed to buy EndoChoice Holdings Inc. for about $210 million to expand its endoscopy business.
The $8-a-share purchase price is almost double EndoChoice’s closing price of $4.22 as of Monday. The deal is expected to complete in the fourth quarter, Marlborough, Massachusetts-based Boston Scientific said Tuesday in a statement.